Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institutes of Health · Grant
Overview
Supports high-risk, potentially transformative basic research on substance use disorders. Projects should test unconventional hypotheses or develop substantially new techniques where supporting evidence is limited and potential impact is high.
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 150000 per year
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next application deadline, including permitted resubmissions: 10 March 2027. Submit by 17:00 local time of the applicant organisation. Call expiration: 12 August 2027. This is separate from the application deadline.
Contact
National Institutes of Health · [email protected]